Advertisement Pharmaceutical Business review - Page 37 of 5257 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 14, 2026

Fortress Biotech receives FDA approval for Zycubo to treat Menkes disease

Fortress Biotech has announced that its subsidiary, Cyprium Therapeutics, received US Food and Drug Administration (FDA) approval for Zycubo (copper histidinate, earlier known as CUTX-101) as a treatment for Menkes disease.

Continue
Zycubo is administered subcutaneously to restore copper balance and maintain appropriate copper levels in affected patients. Credit: luchschenF / Shutterstock.com.
January 14, 2026

BD invests $110m to expand US prefillable syringe production

BD will allocate $100m toward establishing the Neopak Glass Prefillable Syringe production line at Columbus by mid-2026. Credit: JHVEPhoto / Shutterstock.com.
January 13, 2026

SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody

Both companies will jointly oversee early-stage development of the antibody candidates. Credit: SmartPhotoLab / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Atara receives FDA complete response letter for Ebvallo BLA application
  2. Novartis to build fourth US radioligand therapy facility in Florida
  3. MediLink and Roche announce exclusive licensing agreement for YL201c
  4. Takeda and Halozyme sign global agreement for Enhanze technology
  5. Santhera grants Agamree rights to Nxera for DMD

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography